Article
Targeted Alpha Therapy with [ <sup>225</sup> Ac]Ac-Macropa-Isatuximab for CD38-positive Hematological Malignancies
2024-11-03
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Hematological malignancies include diverse cancers related to immune system cells and blood-forming tissue. Treatment resistance and relapse are common despite the introduction of novel therapeutics. Following the development of the PET probe [ 89 Zr]Zr-DFO-isatuximab, targeting the overexpressed CD38 receptor, we developed [ 225 Ac]Ac-Macropa-isatuximab for targeted alpha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5dff7000-5d28-5aa6-945c-6772d0f8c137
- DOI
- 10.1101/2024.11.01.621584
